The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1
- PMID: 12131211
- DOI: 10.1097/00002030-200207050-00006
The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1
Abstract
Objective: To explore the feasibility of expressing the potent HIV-inactivating protein, cyanovirin-N (CV-N), in the human commensal bacterium Streptococcus gordonii, as a possible approach for local delivery of CV-N to prevent sexual transmission of HIV-1.
Design and methods: To express CV-N in S. gordonii, we used the host-vector system we had previously developed. CV-N was expressed as a fusion protein both attached to the bacterial surface and secreted in soluble form in the supernatant of liquid cultures. The soluble form of recombinant CV-N was tested for gp120-binding activity in an enzyme-linked immunosorbent assay, whereas S. gordonii strain expressing CV-N on the surface was analyzed in an in vitro HIV capturing assay.
Results: Two recombinant S. gordonii strains secreting or displaying CV-N on the bacterial surface were constructed and the expression of CV-N was confirmed by immunoblot and flow-cytometric analysis. The secreted form of recombinant CV-N exhibited a concentration-dependent binding to the envelope glycoprotein gp120 of HIV-1, whereas CV-N displayed on the bacterial surface was able to capture HIV virions efficiently.
Conclusion: The anti-HIV protein CV-N in S. gordonii was expressed in a biologically active form. This represents a first step in the development of a system to deliver and maintain an effective concentration of a microbicide in the vaginal mucosa.
Similar articles
-
Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells.Antimicrob Agents Chemother. 2001 Mar;45(3):664-72. doi: 10.1128/AAC.45.3.664-672.2001. Antimicrob Agents Chemother. 2001. PMID: 11181340 Free PMC article.
-
Antigenicity and immunogenicity of the V3 domain of HIV type 1 glycoprotein 120 expressed on the surface of Streptococcus gordonii.AIDS Res Hum Retroviruses. 1999 Mar 20;15(5):451-9. doi: 10.1089/088922299311204. AIDS Res Hum Retroviruses. 1999. PMID: 10195755
-
Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.Antimicrob Agents Chemother. 1997 Jul;41(7):1521-30. doi: 10.1128/AAC.41.7.1521. Antimicrob Agents Chemother. 1997. PMID: 9210678 Free PMC article.
-
Properties of cyanovirin-N (CV-N): inactivation of HIV-1 by sessile cyanovirin-N (sCV-N).Dev Biol (Basel). 2000;102:141-8. Dev Biol (Basel). 2000. PMID: 10794101 Review.
-
Cyanovirin-N: a sugar-binding antiviral protein with a new twist.Cell Mol Life Sci. 2003 Feb;60(2):277-87. doi: 10.1007/s000180300023. Cell Mol Life Sci. 2003. PMID: 12678493 Free PMC article. Review.
Cited by
-
Antiviral Cyanometabolites-A Review.Biomolecules. 2021 Mar 22;11(3):474. doi: 10.3390/biom11030474. Biomolecules. 2021. PMID: 33810129 Free PMC article. Review.
-
Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine.Infect Immun. 2005 Apr;73(4):2360-6. doi: 10.1128/IAI.73.4.2360-2366.2005. Infect Immun. 2005. PMID: 15784582 Free PMC article. Clinical Trial.
-
Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4.Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11672-7. doi: 10.1073/pnas.1934747100. Epub 2003 Sep 12. Proc Natl Acad Sci U S A. 2003. PMID: 12972635 Free PMC article.
-
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria.Nat Rev Microbiol. 2008 May;6(5):349-62. doi: 10.1038/nrmicro1840. Nat Rev Microbiol. 2008. PMID: 18345021 Free PMC article. Review.
-
A Nanobody of PEDV S1 Protein: Screening and Expression in Escherichia coli.Biomolecules. 2024 Sep 4;14(9):1116. doi: 10.3390/biom14091116. Biomolecules. 2024. PMID: 39334881 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources